Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medtronic Inc (MDT)

Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 127,906,544
  • Shares Outstanding, K 1,282,014
  • Annual Sales, $ 33,537 M
  • Annual Income, $ 4,662 M
  • EBIT $ 8,114 M
  • EBITDA $ 10,975 M
  • 60-Month Beta 0.71
  • Price/Sales 3.83
  • Price/Cash Flow 12.94
  • Price/Book 2.63

Options Overview Details

View History
  • Implied Volatility 18.73% (+0.23%)
  • Historical Volatility 16.37%
  • IV Percentile 31%
  • IV Rank 19.43%
  • IV High 41.66% on 04/08/25
  • IV Low 13.20% on 02/04/25
  • Expected Move (DTE 8) 2.10 (2.13%)
  • Put/Call Vol Ratio 0.33
  • Today's Volume 7,511
  • Volume Avg (30-Day) 14,949
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 193,646
  • Open Int (30-Day) 203,704
  • Expected Range 96.59 to 100.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 01/31/26
See More
  • Average Estimate 1.33
  • Number of Estimates 11
  • High Estimate 1.34
  • Low Estimate 1.33
  • Prior Year 1.39
  • Growth Rate Est. (year over year) -4.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
95.17 +3.70%
on 01/05/26
102.00 -3.25%
on 12/09/25
-2.57 (-2.54%)
since 12/08/25
3-Month
89.04 +10.84%
on 11/03/25
106.33 -7.19%
on 11/26/25
+0.82 (+0.84%)
since 10/08/25
52-Week
79.55 +24.06%
on 04/09/25
106.33 -7.19%
on 11/26/25
+16.01 (+19.36%)
since 01/08/25

Most Recent Stories

More News
Study showed MiniMedâ„¢ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus

GALWAY, Ireland , Jan. 7, 2026 /PRNewswire/ -- A new real-world retrospective analysis published in Diabetes Care  showed that users of the MiniMed™ 780G system achieved American Diabetes...

MDT : 98.69 (-1.08%)
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

GALWAY, Ireland , Jan. 5, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conference...

MDT : 98.69 (-1.08%)
3 Best Dividend Aristocrats to Buy in 2026

These Dividend Aristocrats have strong earnings growth, solid yields, and Wall Street buy ratings stand out as smart income plays for 2026.

SWK : 81.49 (+3.56%)
FRT : 102.80 (+1.11%)
MDT : 98.69 (-1.08%)
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed

GALWAY, Ireland , Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will...

MDT : 98.69 (-1.08%)
Is Insulet Stock Underperforming the Nasdaq?

Although Insulet has underperformed the Nasdaq recently, analysts remain highly optimistic about the stock’s prospects.

$NASX : 23,480.02 (-0.44%)
PODD : 292.89 (-2.10%)
MDT : 98.69 (-1.08%)
AI Turns Health and Wellness Data into Gold as $110B Market Explodes by 2030

Issued on behalf of Aleen Inc. VANCOUVER – Baystreet.ca News Commentary – Artificial intelligence is turning fragmented health data into actionable insights, fundamentally reshaping how patients,...

ABT : 126.18 (-0.68%)
WELL.TO : 4.10 (+0.99%)
MDT : 98.69 (-1.08%)
WHTCF : 2.9365 (-2.44%)
RDNT : 78.38 (+1.25%)
ALEN-U.CN : 1.3000 (unch)
Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting

Joint presentation by Orchestra BioMed and Medtronic leadership to discuss ongoing strategic collaboration for development and commercialization of AVIM Therapy for treatment of uncontrolled hypertension...

MDT : 98.69 (-1.08%)
OBIO : 4.84 (+1.04%)
Medtronic announces FDA clearance of Hugoâ„¢ robotic-assisted surgery system for urologic surgical procedures

Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a connected and integrated operating room today and into the future.

MDT : 98.69 (-1.08%)
Medtronic begins U.S. commercial launch of the MiniMedâ„¢ 780G system with the Instinct sensor, made by Abbott

GALWAY, Ireland , Dec. 2, 2025  /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated...

MDT : 98.69 (-1.08%)
How Is Medtronic's Stock Performance Compared to Other Medical Devices Stocks?

Medtronic has outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.

ABT : 126.18 (-0.68%)
IHI : 64.20 (-0.16%)
MDT : 98.69 (-1.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience...

See More

Key Turning Points

3rd Resistance Point 101.57
2nd Resistance Point 100.98
1st Resistance Point 99.84
Last Price 98.69
1st Support Level 98.11
2nd Support Level 97.52
3rd Support Level 96.38

See More

52-Week High 106.33
Last Price 98.69
Fibonacci 61.8% 96.10
Fibonacci 50% 92.94
Fibonacci 38.2% 89.78
52-Week Low 79.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar